Background: Genome scans for hypertension have yielded inconsistent results. The non-replication of significant or suggestive linkage might be due to lack of power of individual studies. Here, we conducted a genome scan meta-analysis for hypertension in an attempt to increase statistical power and to enhance evidence of linkage.
H
ypertension is a significant risk factor for many types of coronary artery diseases and for cerebrovascular, peripheral vessel, and renal diseases. Diseases associated with hypertension cause more than 12 million deaths annually worldwide and impose a major burden on health care resources. The identification of hypertension-susceptibility genes would have obvious implications for prevention, diagnosis, and treatment of hypertension. Since the late 1980s, 1 tremendous effort has been made to localize genes predisposing to hypertension. Genome scans for hypertension have yielded loci linked to hypertension on many chromosomes, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] and discrepancies exist among the different studies. These inconsistent results imply that there is no major locus that consistently raises the risk of hypertension. The inherited basis of hypertension is probably polygenic with complicated gene-gene and gene-environment interactions.
Although many studies claimed to detect linkage, many of these significant peaks become "suggestive" or disappear after applying the strict genome-wide criteria of Lander and Kruglyak for significance in genome scans. 14, 15 Therefore, one must be cautious in accepting these studies. Statistical power is affected by many factors including the relative risk of the trait, the informativeness of the marker, the density of the marker, and the number of affected individuals. Power can usually be improved by increasing the sample size or in a combined analysis in which data from different studies can simultaneously be taken into account. A combined analysis of hypertension genome scans was conducted by Province et al in 2003. 16 They used the old meta-analysis technique, developed by Fisher, 17 the method of combining P values to pool the genome-wide scans for hypertension from four multicenter networks (GenNet, GENOA, HyperGEN, SAPPHIRe) from the National Heart, Lung and Blood Institute Family Blood Pressure Program (FBPP) into a single genome-wide linkage scan. The Fisher method does not require different studies to use the same test, but it does require the same set of genetic markers to be used in different studies. Fortunately, the four networks used exactly the same set of markers. None of the four individual network studies provides definite evidence of linkage, but regions of suggestive linkage have been identified. Despite the large sample size (N ϭ 6245 relatives) of the metaanalysis, Province et al did not find any enhanced evidence of linkage. Interestingly, the linkage evidence actually decreased as they included more individuals in their metaanalysis. Consequently, Province et al stated in their paper that "there were no genomic regions having uniformly large impact on BP levels or predisposition to hypertension in the general populations of non-Hispanic whites, African Americans and Asians."
Despite the flexibility of statistical tests of the P value method, the Fisher meta-analysis approach cannot be used to pool genome scans with different marker sets, which greatly limits its application. In this study, we used another Genome Search Meta-analysis (GSMA) method recently developed by Wise et al and Levinson et al 18, 19 to combine genome scan results of six datasets from five papers [2] [3] [4] [5] [6] in an attempt to find enhanced evidence of linkage. The GSMA method uses a non-parametric ranking method to identify genomic regions that show consistent linkage evidence based on the LOD scores or P values obtained in each scan. This method allows methodological differences and can be used to pool scans with a diversity of study designs and different sets of genetic markers. It ranks LOD score (or other) statistics within each scan and then compares ranks of the genetic regions across different studies.
The GSMA method can confirm significant regions identified in the original scans and detect new regions, which did not reach significance level in the original scans.
Methods

Subjects
The GSMA method requires knowledge of P values or test statistics throughout the genome (X chromosome may be excluded) or results above a strict LOD score or P value cut-off. Therefore, genome scans with results reported only for chromosome(s) in which significant or suggestive linkage was found cannot be used in the meta-analysis. Some scans reported results for too few markers and were also excluded from the meta-analysis. The main characteristics of published genome scans are summarized in Table 1 . Six scans from five papers 2-6 satisfied the GSMA requirements and were used in the meta-analysis. For all selected scans, full chromosomal results were either published in the original papers or posted on the World Wide Web. Details of subject inclusion/exclusion criteria of six selected genome scans were described in the original papers.
2-6 One paper 3 analyzed white and African American populations separately and thus was treated here as two independent scans. Since one study 3 reported genome scan results only for the 22 autosomal chromosomes, we ignored the X-chromosome in the meta-analysis. In addition to using all available individuals, some scans also performed stratified analyses according to sex, geographic locations, 5 and sib pair concordance status. 2 Only the results obtained from the unstratified analyses were used in the meta-analysis here. The six scans differed in many aspects of study designs including sample size, ethnicity, linkage tests, and marker sets. Hypertension was defined using similar criteria across the studies. All studies recruited families with at least one hypertensive individual.
GSMA
Details of the GSMA methodology are presented in the original papers 18, 19 and are only briefly summarized here.
The GSMA method splits the chromosomes into bins of approximately equal length. For each genome screen, the bins are ranked according to the most significant result obtained within each bin. The bin with the most significant result is assigned the highest rank. The ranks for each bin are summed across different genome scans. For any bin, the null hypothesis is that the ranks are randomly distributed. If the individual screen results are treated equally (unweighted analysis), the probability of the summed rank (R) for a particular bin follows:
where x i indicates the rank of the bin in the ith study, m and n represent the number of studies and bins respectively, and d is the integer part of (RϪm)/n. If individual screen results contribute differently to the meta-analysis (weighted analysis), we can weigh the results from each screen by multiplying a weighting factor to the observed ranks. Here we used the square root of the number of cases in a particular screen divided by the mean of the square roots over all screens as our weighting factor to give weights with a mean value of 1. For weighted analysis, the average rank (R avg ) is computed for each bin across all m studies. The probability of the average rank (P avgRnk ) can be determined by permutation. For each permutated replicate, the observed ranks for each screen are randomly reassigned to bins and then averaged across studies for each bin. The value P avgRnk is the proportion of bins in the random replicates with R avg greater than the observed R avg .
To ensure the correlation between adjacent bins to be small and at least two bins on the smallest chromosome, we divided the autosomal chromosomes into 120 bins with a bin width of approximate 30 cM, as suggested by the original GSMA papers. 18, 19 To get stable estimates of the probabilities, we permuted the observed ranks 10,000 times.
Results
The GSMA was applied to six genome screens [2] [3] [4] [5] [6] to look for regions linked to hypertension. The genome scan metaanalysis shows regions of suggestive linkage on several chromosomes. Figure 1 displays the weighted GSMA results on all automosal chromosomes. The 90th, 95th, and 99th percentiles were calculated from the 10,000 random permuted replicates. In the weighted analysis, seven circles from five chromosomes lie above the 90th percentile. Four circles from three chromosomes appear above the 95% threshold and one circle lies above the 99th percentile. Table 2 lists the regions with P values Ͻ.1 in either the 19 Interestingly, this region did not show significant or suggestive linkage in any of the six individual genome screens. However, this region did exhibit evidence of linkage in a recent study conducted by Sharma et al. 8 Their sibpair linkage analysis yielded a P value of .004. The low P value provided by the metaanalysis in this region indicated that this region ranked relatively high among all of the genomic regions consistently across all six screens, although it did not reach the significance level in any of the individual studies.
Besides the region on chromosome 11, several other regions show suggestive linkage in either the unweighted or weighted or both analyses, including 2p, 5q, 6q, 8p, 9p, 9q and another region on 11q, as shown in Table 2 . One region on 6q (bin 6.6) exhibited significant linkage, and one region on 5q (bin 5.3) demonstrated suggestive linkage in one of the six genome screens. 4 The region on 2p also showed suggestive linkage in two of the six genome searches. 3, 6 However, the other regions identified by the GSMA analysis did not even show suggestive linkage in the individual genome searches. The significant linkage found on 6q in one study 4 became suggestive linkage and the significant linkages identified on 3q and 18q in the individual studies 5, 6 completely disappeared in our pooled analysis. A couple of suggestive linked regions identified by GSMA also showed significant or suggestive linkage in blood pressure genome scans, including bin 2.4 on 2p 20 -24 and bin 11.4 on 11q. 21 In addition to genome scans, a candidate gene study revealed an association between DNA variations in the adrenomedullin (AM) gene on 11p (bin 11.4) and the predisposition to hypertension. 25 Several other regions identified by GSMA also harbor genes found to be associated with the predisposition to hypertension or blood pressure regulation in candidate gene studies including the beta 2 -adrenergic receptor gene in bin 5.5, 26,27 the major histocompatibility complex in bin 6.4, 28 and the lipoprotein lipase gene locus in bin 8.1.
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Discussion
A major problem in genetic analysis of complex diseases is replication of linkage results across different studies. One possible reason for the nonreplication of significant or suggestive linkage is the lack of power of individual studies. Here we have carried out a meta-analysis of hypertension genome scans from more than 8000 individuals taking part in five studies using the newly developed GSMA method in an attempt to increase statistical power and to enhance evidence of linkage. Unfortunately, our analysis did not find any region with genome-wide significance. Our analysis did, however, reveal several regions with suggestive linkage. These regions showed relatively consistent high ranks across different screens and might be worth further investigation as containing genes with smallto-moderate effects on hypertension. Our results are not comparable to those obtained by Province et al. 16 In contrast to the peak LOD score on chromosome 10p found by Province et al, the lowest P value provided by our analysis occurred on chromosome 11q. The discrepancy reflects the differences in the individuals included in the study and the meta-analysis methods used.
The failure of our analysis to find enhanced evidence of linkage implies that significant or suggestive linkages found in the individual searches may be due to falsepositive results or may represent population-specific susceptibility genes. A common belief is that power can be increased with larger sample sizes. However, increasing the sample size does not necessarily increase Weighted results of Genome Search Meta-analysis (GSMA) from the six hypertension genome scans. Horizontal axis represents the 22 automosomal chromosomes; vertical axis represents average weighted ranks. The 90th, 95th, and 99th percentiles were calculated from the 10,000 random permuted replicates. Circles above the 90th percentile have less than 10% probability of occurring within any bin; circles above the 95th percentile have less than 5% probability, and the circles above the 99th percentile have less than 1% probability of occurring within any bin.
the chance of detecting linkage. Although the metaanalysis significantly increased the sample size, it also introduced heterogeneity, arising, for example, from phenotypic differences between different populations, ethnic and racial differences, and geographic location differences, which might even decrease the chance of obtaining a significant result. So many intermediate pathways contribute to variability in blood pressure and hypertension that it is unlikely for a single locus to exert much influence. Different hypertension genes might operate in different ethnic groups or even different subsets of families and thus become undetectable in the combined analysis. Another explanation for lack of enhanced evidence of linkage is that gene-gene and geneenvironment interaction may be at play. Complex genetic and environmental conditions might be required for the hypertension genes to express, which introduces more heterogeneity and further complicates detection in the combined analysis. Furthermore, other phenotypes, such as obesity, insulin resistance, and hyperlipidemia, each of which may have its own genetic component, may confound hypertension genetic analysis.
In conclusion, our meta-analysis further demonstrated that no single genomic region had uniformly large impact on hypertension and the genetic determination of hypertension may truly be polygenic. Although the difficulty in publishing negative findings limits the value of metaanalysis, meta-analysis remains a promising tool to localize regions linked to hypertension. Consistency of the linkage evidence across different studies may be more indicative of a true linkage than the actual magnitude of any one finding. 
